Access to Antihypertensive Drugs in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Access to Antihypertensive Drugs in China

Published:2018-10-23 Issue:17 Volume:138 Page:1777-1779
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Bai Ge¹,Bennet Catherine²,Wang Jiguang³,Anderson Gerard F.⁴

Affiliation:

1. The Johns Hopkins Carey Business School, Washington, DC (B.G.).

2. The Johns Hopkins School of Medicine, Baltimore, MD (C.B.).

3. Shanghai Jiao Tong University School of Medicine, China (J.W.).

4. The Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (G.F.A.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. China CVD report 2016.;Chen W;Chin Circ J,2017

2. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project)

3. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study

4. Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey

5. Changing of China׳s health policy and Doctor–Patient relationship: 1949–2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lowering of systolic blood pressure in hypertensive patients: insights and questions from the ESPRIT study;Blood Pressure;2024-09-06

2. Applications and outcomes of implementing telemedicine for hypertension management in COVID-19 pandemic: A systematic review;PLOS ONE;2024-08-01

3. Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review;Public Health Reviews;2022-09-02

4. Antihypertensive activity of indole and indazole analogues: A review;Arabian Journal of Chemistry;2022-05

5. Blood Pressure Control, Accessibility, and Adherence to Antihypertensive Medications: Patients Seeking Care in Two Hospitals in the Ashanti Region of Ghana;International Journal of Hypertension;2021-07-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3